Skip to search formSkip to main contentSkip to account menu

GT 2331

Known as: GT-2331 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
An investigation of the absolute configuration of the potent histamine H3 receptor antagonist GT-2331 using vibrational circular dichroism.
GT-2331 [(+)-1] is one of the most potent members of a class of chiral drug substances used to regulate the synthesis and release… 
2006
2006
Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor.
2005
2005
G Protein-Dependent Pharmacology of Histamine H3 Receptor Ligands: Evidence for Heterogeneous Active State Receptor Conformations
Previously reported pharmacological studies using the imidazole-containing histamine H3 receptor ligands GT-2331 (Cipralisant… 
2004
2004
An efficient multigram synthesis of the potent histamine H3 antagonist GT-2331 and the reassessment of the absolute configuration.
GT-2331 is a potent histamine H(3) antagonist which has entered clinical trials. Efficient multigram syntheses of this compound… 
2002
2002
Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia model
Highly Cited
2002
Highly Cited
2002
Effects of histamine H3 receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup
2000
2000
Histamine H3 receptor antagonists
The histamine H3 receptor provides a negative feedback mechanism for the release and synthesis of histamine. On non-histaminergic… 
1999
1999
Development of trans-2-[1H-imidazol-4-yl] cyclopropane derivatives as new high-affinity histamine H3 receptor ligands.
Previously, a novel series of 1H-4-substituted imidazole compounds were described as potent and selective histamine (HA) H3… 
1998
1998
High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models.
1998
1998
Pharmacological characterization of GT-2331, a new CNS-penetrating high affinity histamine H3 receptor antagonist
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License